Exact Sciences Stock Performance
The firm owns a Beta (Systematic Risk) of 0.0, which means not very significant fluctuations relative to the market. the returns on MARKET and EXACT Sciences are completely uncorrelated.
Risk-Adjusted Performance
Solid
Weak | Strong |
Over the last 90 days EXACT Sciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, EXACT Sciences is not utilizing all of its potentials. The recent stock price uproar, may contribute to short-horizon losses for the private investors. ...more
| Begin Period Cash Flow | 609.7 M | |
| Total Cashflows From Investing Activities | -442.2 M |
EXACT Sciences Relative Risk vs. Return Landscape
If you would invest 0.00 in EXACT Sciences on September 3, 2025 and sell it today you would earn a total of 0.00 from holding EXACT Sciences or generate 0.0% return on investment over 90 days. EXACT Sciences is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than EXACT, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
EXACT Sciences Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for EXACT Sciences' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as EXACT Sciences, and traders can use it to determine the average amount a EXACT Sciences' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| EXAS |
Based on monthly moving average EXACT Sciences is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of EXACT Sciences by adding EXACT Sciences to a well-diversified portfolio.
EXACT Sciences Fundamentals Growth
EXACT Stock prices reflect investors' perceptions of the future prospects and financial health of EXACT Sciences, and EXACT Sciences fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on EXACT Stock performance.
| Return On Equity | -0.35 | ||||
| Return On Asset | -0.0109 | ||||
| Profit Margin | (0.32) % | ||||
| Operating Margin | (0) % | ||||
| Current Valuation | 20.74 B | ||||
| Shares Outstanding | 189.77 M | ||||
| Price To Earning | (38.17) X | ||||
| Price To Book | 7.68 X | ||||
| Price To Sales | 6.23 X | ||||
| Revenue | 2.76 B | ||||
| EBITDA | (789.33 M) | ||||
| Cash And Equivalents | 728.04 M | ||||
| Cash Per Share | 4.11 X | ||||
| Total Debt | 2.75 B | ||||
| Debt To Equity | 0.77 % | ||||
| Book Value Per Share | 13.20 X | ||||
| Cash Flow From Operations | 210.54 M | ||||
| Earnings Per Share | (5.35) X | ||||
| Total Asset | 5.93 B | ||||
| Retained Earnings | (4.5 B) | ||||
| Current Asset | 325.86 M | ||||
| Current Liabilities | 26.72 M | ||||
Things to note about EXACT Sciences performance evaluation
Checking the ongoing alerts about EXACT Sciences for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for EXACT Sciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| EXACT Sciences is not yet fully synchronised with the market data | |
| EXACT Sciences has some characteristics of a very speculative penny stock | |
| The company reported the previous year's revenue of 2.76 B. Net Loss for the year was (1.03 B) with profit before overhead, payroll, taxes, and interest of 2.14 B. | |
| EXACT Sciences has a poor financial position based on the latest SEC disclosures | |
| Over 95.0% of the company shares are held by institutions such as insurance companies |
- Analyzing EXACT Sciences' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether EXACT Sciences' stock is overvalued or undervalued compared to its peers.
- Examining EXACT Sciences' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating EXACT Sciences' management team can have a significant impact on its success or failure. Reviewing the track record and experience of EXACT Sciences' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of EXACT Sciences' stock. These opinions can provide insight into EXACT Sciences' potential for growth and whether the stock is currently undervalued or overvalued.
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Tools for EXACT Stock
When running EXACT Sciences' price analysis, check to measure EXACT Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EXACT Sciences is operating at the current time. Most of EXACT Sciences' value examination focuses on studying past and present price action to predict the probability of EXACT Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move EXACT Sciences' price. Additionally, you may evaluate how the addition of EXACT Sciences to your portfolios can decrease your overall portfolio volatility.
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |